Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study.
Authors:
Journal: International journal of geriatric psychiatry
Publication Type: Journal Article
Date: 2019
DOI: NIHMS1022171
ID: 30924200
Abstract
Insulin resistance is a substantial health issue for American Indians, with type 2 diabetes overrepresented in this population as compared with non-Hispanic whites. Insulin resistance and its related conditions in turn increase risk for dementia and cognitive impairment. The aim of the current study was to determine whether type 2 diabetes and insulin resistance at midlife was associated with later-life cognitive testing in a large sample of older American Indians, aged 65 and older.
Reference List
- Hutchinson RN, Shin S. Systematic review of health disparities for cardiovascular diseases and associated factors among American Indian and Alaska Native populations. PLoS One. 2014;9(1):e80973.|||Prevention CfDCa. Diabetes prevalence among American Indians and Alaska Natives and the overall population- United States, 1994–2002. Morb Mortal Wkly Rep. 2004;52 (30):702–704.|||Luchsinger JA. Diabetes, related conditions, and dementia. J Neurol Sci. 2010;299(1–2):35–38.|||Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4(6):640–650.|||Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–2713.|||Ahmed S, Mahmood Z, Zahid S. Linking insulin with Alzheimer’s disease: emergence as type III diabetes. Neurol Sci. 2015;36(10):1763–1769.|||Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 2002;959:368–383.|||Backestrom A, Eriksson S, Nilsson LG, Olsson T, Rolandsson O. Glucose but not insulin or insulin resistance is associated with memory performance in middle-aged non-diabetic women: a cross sectional study. Diabetol Metab Syndr. 2015;7:20.|||Frazier DT, Bettcher BM, Dutt S, et al. Relationship between Insulin-Resistance Processing Speed and Specific Executive Function Profiles in Neurologically Intact Older Adults. J Int Neuropsychol Soc. 2015:1–7.|||Schuur M, Henneman P, van Swieten JC, et al. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol. 2010;25(8):561–568.|||Willette AA, Bendlin BB, Starks EJ, et al. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol. 2015;72(9):1013–1020.|||Sadanand S, Balachandar R, Bharath S. Memory and executive functions in persons with type 2 diabetes: a meta-analysis. Diabetes Metab Res Rev. 2015.|||Zhao Q, Roberts RO, Ding D, et al. Diabetes is Associated with Worse Executive Function in Both Eastern and Western Populations: Shanghai Aging Study and Mayo Clinic Study of Aging. J Alzheimers Dis. 2015;47(1):167–176.|||Masdeu JC, Kreisl WC, Berman KF. The neurobiology of Alzheimer disease defined by neuroimaging. Curr Opin Neurol. 2012;25(4):410–420.|||Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280–292.|||Meng XF, Yu JT, Wang HF, et al. Midlife vascular risk factors and the risk of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;42(4):1295–1310.|||Tolppanen AM, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer’s disease: evidence from epidemiological studies. J Alzheimers Dis. 2012;32(3):531–540.|||Roberts RO, Knopman DS, Przybelski SA, et al. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 2014;82(13):1132–1141.|||Tolppanen AM, Lavikainen P, Solomon A, et al. History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study. Diabetes Care. 2013;36(7):2015–2019.|||Willette AA, Johnson SC, Birdsill AC, et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement. 2014.|||Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132(6):1141–1155.|||Suchy-Dicey A, Shibata D, Best LG, et al. Cranial magnetic resonance imaging in elderly American Indians: Design, methods, and implementation of the Cerebrovascular Disease and Its Consequences in American Indians study. Methods in Neuroepidemiology. 2016;In press.|||Kamboh MI, Ferrell RE, Kottke B. Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res. 1988;29(11):1535–1543.|||North KE, Goring HH, Cole SA, et al. Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study. J Lipid Res. 2006;47(1):59–66.|||Zhang Y, Lee ET, Howard BV, et al. Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study. Diabetes Care. 2013;36(10):3195–3200.|||Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.|||Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48(8):314–318.|||Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test - Second Edition San Antonio, TX: Pearson; 2000.|||Wechsler D Wechsler Adult Intelligence Scale - Fourth Edition. San Antonio, TX: Pearson; 2008.|||Spreen O, Strauss EA. A Compendium of Neuropsychological Tests. NY: Oxford University Press; 1991.|||Steptoe A, Hackett RA, Lazzarino AI, et al. Disruption of multisystem responses to stress in type 2 diabetes: investigating the dynamics of allostatic load. Proc Natl Acad Sci U S A. 2014;111(44):15693–15698.|||Kapasi A, Schneider JA. Vascular contributions to cognitive impairment, clinical Alzheimer’s disease, and dementia in older persons. Biochim Biophys Acta. 2016.|||Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423–436.|||Schinzari F, Tesauro M, Rovella V, et al. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab. 2010;299(6):E947–952.|||Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11(3):261–271.|||Tamura Y, Araki A. Diabetes mellitus and white matter hyperintensity. Geriatr Gerontol Int. 2015;15 Suppl 1:34–42.|||Kearney MT, Duncan ER, Kahn M, Wheatcroft SB. Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol. 2008;93(1):158–163.|||Tabit CE, Shenouda SM, Holbrook M, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation. 2013;127(1):86–95.|||Vendemiale G, Romano AD, Dagostino M, de Matthaeis A, Serviddio G. Endothelial dysfunction associated with mild cognitive impairment in elderly population. Aging Clin Exp Res. 2013;25(3):247–255.|||Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging S. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes. 2002;51(4):1256–1262.|||Cholerton B, Larson EB, Baker LD, et al. Neuropathologic correlates of cognition in a population-based sample. J Alzheimers Dis. 2013;36(4):699–709.|||Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis. J Neuropsychol. 2015;9(1):109–136.|||McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379(9833):2291–2299.|||Monette MC, Baird A, Jackson DL. A meta-analysis of cognitive functioning in nondemented adults with type 2 diabetes mellitus. Can J Diabetes. 2014;38(6):401–408.|||Abner EL, Nelson PT, Kryscio RJ, et al. Diabetes is associated with cerebrovascular but not Alzheimer neuropathology. Alzheimers Dement. 2016.|||Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74.|||Mayeda ER, Karter AJ, Huang ES, Moffet HH, Haan MN, Whitmer RA. Racial/ethnic differences in dementia risk among older type 2 diabetic patients: the diabetes and aging study. Diabetes Care. 2014;37(4):1009–1015.|||Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. In: Centers for Disease Control and Prevention UDoHaHS, ed. Atlanta, GA: 2017.|||Lee ET, Welty TK, Cowan LD, et al. Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study. Diabetes Care. 2002;25(1):49–54.|||Bangen KJ, Gu Y, Gross AL, et al. Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort. J Am Geriatr Soc. 2015;63(6):1075–1083.|||Mayeda ER, Whitmer RA, Yaffe K. Diabetes and cognition. Clin Geriatr Med. 2015;31(1):101–115, ix.|||Yaffe K, Peltz CB, Ewing SK, et al. Long-term Cognitive Trajectories and Mortality in Older Women. J Gerontol A Biol Sci Med Sci. 2016.